Axalta Coating Systems heads into the final session of June with shorts exiting, analyst confidence rebuilding, and options markets leaning firmly bullish — a notably cleaner setup than the stock carried a month ago.
The most striking move this week came from the Street. Mizuho raised its price target on Axalta to $39 from $32 on July 1, while keeping an Outperform rating — a 22% lift that reverses the same firm's cut back in late March. That single action pushes the mean analyst target to $36.21, still below the stock's $34.22 close but not by much. Citigroup reinstated coverage in early June at Buy with a $44 target, adding further conviction to the bull camp. The divergence between those constructive views and the more cautious posture at RBC (Sector Perform, $29 target) and UBS (Neutral, $32) captures the live debate: bulls are pointing at operational efficiency gains and automotive refinish demand; bears are not yet convinced the macro tailwinds are durable enough to warrant a re-rating. The stock's P/E has expanded by roughly 2 points over the past 30 days to 12.9x — cheap on its face, but the EP factor scores mid-table at 49, suggesting the market is not yet treating that cheapness as a catalyst on its own.
The positioning picture reinforces the constructive lean. Short interest has dropped 12% on the week to 3.5% of the free float — roughly 7.5 million shares — continuing a trend that has seen bears pare back from near 8.9 million shares in late May. That is a meaningful retreat, even if the absolute level remains modest. Borrowing costs are low at 0.45% and falling, off 22% on the week, making it cheap to maintain a short position for anyone who wants one. Availability is exceptionally loose at nearly 2,400% — the lending pool has more than 27 shares available for every one currently borrowed — so there is no mechanical squeeze pressure here. The ORTEX short score has also drifted lower this week to 35, consistent with a market where bears are quietly stepping back.
Options markets are delivering the clearest bullish signal in the dataset. The put/call ratio has fallen to 0.26, more than one standard deviation below its 20-day average of 0.32, and sits near the low end of its range after having been as high as 0.68 in mid-May. The persistent gap between where call positioning was six weeks ago and where it is now tracks almost precisely with the stock's 11% gain over the past month. That rotation out of puts and into calls is not subtle — it reflects growing conviction that the upside case is more live than the downside one.
The earnings calendar adds near-term relevance. Axalta reports Q2 results on July 30. Recent history at the print is mixed: Q1 results in May saw the stock fall 6% on day one before recovering 2.4% over the week; the prior print produced a smaller 1.7% initial dip with a similar pattern of recovery. That one-day dip, five-day recovery pattern is worth keeping in mind given the current configuration — with peers PPG and RPM up 3% and 4.8% on the week respectively, and SHW up 6.6%, Axalta is not yet the outperformer of the group despite the cleaner short and options backdrop.
The July 30 print is the next inflection point — how the stock handles another potential day-one dip, and whether the rebuilt analyst conviction in the $39–$44 target range holds into the number, will define whether this week's short-cover rally has substance behind it.
See the live data behind this article on ORTEX.
Open AXTA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
